# MTOR Inhibitors in Older Adults

> **NCT06727305** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Aging

## Interventions

- **DRUG:** Sirolimus 0.5 Mg Oral Tablet
- **DRUG:** Sirolimus 1Mg Oral Tablet
- **DRUG:** Sirolimus 2 MG Oral Tablet
- **DRUG:** Everolimus 0.5 MG Oral Tablet
- **DRUG:** Everolimus 1 MG Oral Tablet
- **DRUG:** Everolimus 2 MG Oral Tablet

## Key facts

- **NCT ID:** NCT06727305
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-11-13
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06727305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06727305, "MTOR Inhibitors in Older Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06727305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*